The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTION
Abstract
BACKGROUND: Mycophenolate Mofetil (MMF) has been shown to significantly decrease the number of acute rejection episodes in renal transplant recipients during the 1st year. A beneficial effect of MMF on long-term graft survival has been more difficult to demonstrate. This beneficial effect has not been detected, despite the impact of acute rejection on the development of chronic allograft nephropathy and experimental evidence that MMF may have a salutary effect on chronic allograft nephropathy independent of that of rejection. METHODS: Data on 66,774 renal transplant recipients from the U.S. renal transplant scientific registry were analyzed. Patients who received a solitary renal transplant between October 1, 1988 and June 30, 1997 were studied. The Cox proportional hazard regression was used to estimate relevant risk factors. Kaplan-Meier analysis was performed for censored graft survival. RESULTS: MMF decreased the relative risk for development of chronic allograft failure (CAF) by 27% (risk ratio [RR] 0.73, P<0.001). This effect was independent of its outcome on acute rejection. Censored graft survival using MMF versus azathioprine was significantly improved by Kaplan-Meier analysis at 4 years (85.61% v. 81.9%). The effect of an acute rejection episode on the risk of developing CAF seems to be increasing over time (RR=1.9, 1988-91; RR=2.9, 1992-94; RR=3.7, 1995-97). CONCLUSION: MMF therapy decreases the risk of developing CAF. This improvement is only partly caused by the decrease in the incidence of acute rejection observed with MMF; but, is also caused by an effect independent of acute rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Transplantation · doi:10.1097/00007890-199604150-00008 · Cited by 1,055
Grinyo, J. M., GROTH, C. G., Pichlmayr, R., Sadek, S., Vanrenterghem, Y. F. C., Behrend, M., Luck, R. P., Moreso, F., Peeters, J. A. G., Rodicio, J. L., et al. (1995) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 974
European Mycophenolate Mofetil Cooperative Study Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)92534-1 · Cited by 927
Groth, C. G., Bäckman, L., Morales, J.-M., Calne, R., Kreis, H., Lang, P., Touraine, J.-L., Claesson, K., Campistol, J. M., Durand, D., et al. (1999) · Transplantation · doi:10.1097/00007890-199904150-00017 · Cited by 878
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
Vincenti, F., Kirkman, R., Light, S., Bumgardner, G., Pescovitz, M., Halloran, P., Neylan, J., Wilkinson, A., Ekberg, H., Gaston, R., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380304 · Cited by 864
Nashan, B., Moore, R., Amlot, P., Schmidt, A.-G., Abeywickrama, K., & Soulillou, J.-P. (1997) · The Lancet · doi:10.1016/s0140-6736(97)09278-7 · Cited by 749
Kahan, B. D., Rajagopalan, P. R., & Hall, M. (1999) · Transplantation · doi:10.1097/00007890-199901270-00016 · Cited by 476
Rethinking Chronic Allograft Nephropathy: The Concept of Accelerated Senescence
HALLORAN, P. F., MELK, A., & BARTH, C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v101167 · Cited by 452
Chronic allograft nephropathy: An update
Paul, L. C. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00611.x · Cited by 364
REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1
Nashan, B., Light, S., Hardie, I. R., Lin, A., & Johnson, J. R. (1999) · Transplantation · doi:10.1097/00007890-199901150-00019 · Cited by 302
Cited by
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Strategies to Improve Long-Term Outcomes after Renal Transplantation
Pascual, M., Theruvath, T., Kawai, T., Tolkoff-Rubin, N., & Cosimi, A. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011295 · Cited by 844
Taylor, A. L., Watson, C. J. E., & Bradley, J. A. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.03.012 · Cited by 445
Mechanisms of Action of Mycophenolate Mofetil in Preventing Acute and Chronic Allograft Rejection
Allison, A. C., & Eugui, E. M. (2005) · Transplantation · doi:10.1097/01.tp.0000186390.10150.66 · Cited by 357
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation
van Gelder, T., Meur, Y. L., Shaw, L. M., Oellerich, M., DeNofrio, D., Holt, C., Holt, D. W., Kaplan, B., Kuypers, D., Meiser, B., et al. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000199358.80013.bd · Cited by 331
Self-citation
Metadata
- Authors
- Ojo, A. O., Meier-Kriesche, H.-U., Hanson, J. A., Leichtman, A. B., Cibrik, D., Magee, J. C., Wolfe, R. A., Agodoa, L. Y., & Kaplan, B.
- Venue
- Transplantation
- Published
- 2000-06
- Volume
- 69
- Issue
- 11
- Pages
- 2405-2409
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2131290131
- Cited by
- 400
- References
- 17
- FWCI
- 24.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTION. https://app.cochat.ai/papers/10.1097/00007890-200006150-00033
- The paper
- Ojo, A. O., Meier-Kriesche, H.-U., Hanson, J. A., Leichtman, A. B., Cibrik, D., Magee, J. C., Wolfe, R. A., Agodoa, L. Y., & Kaplan, B. (2000). MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTION. Transplantation. https://doi.org/10.1097/00007890-200006150-00033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.